Chapter 22_ Oxidation of Fatty Acids_ Ketogenesis
Chapter 22: Oxidation of Fatty Acids: Ketogenesis
Objectives
Fatty Acid Transport and Activation
Describe the processes for transporting fatty acids in the blood.
Explain activation and transport of fatty acids into mitochondria.
β-Oxidation Pathway
Outline the β-oxidation pathway leading to acetyl-CoA production.
Explain ATP yield from fatty acid metabolism.
Ketone Bodies
Identify the three ketone bodies: acetoacetate, D-3-hydroxybutyrate, acetone.
Describe formation reactions in liver mitochondria.
Recognize conditions favoring ketone body synthesis.
Regulation of Ketogenesis
Indicate three stages of fatty acid metabolism regulation.
Understand risks of overproduction leading to ketosis and ketoacidosis.
Identify diseases linked to impaired fatty acid oxidation.
Biomedical Importance
Fatty acids are oxidized in mitochondria to acetyl-CoA, generating high energy.
Ketone Bodies and Their Role
Produced during high rates of fatty acid oxidation (acetoacetate, D-3-hydroxybutyrate, acetone).
Ketosis occurs during starvation and diabetes, leading to potential ketoacidosis due to the acidic nature of ketone bodies.
Impaired fatty acid oxidation can result in hypoglycemia, particularly in conditions of carnitine deficiency or enzyme deficiencies.
Fatty Acid Oxidation in Mitochondria
Separation of Processes
Breakdown of fatty acids is distinct from fatty acid synthesis, allowing individual control.
Fatty acids are transported as Free Fatty Acids (FFA).
Long-chain FFA bind to albumin in plasma, while shorter chains are more soluble.
Activation of Fatty Acids
Fatty acids must convert to acyl-CoA for catabolism (requires ATP).
Catalyzed by acyl-CoA synthetase, producing AMP and PPi.
PPi is hydrolyzed by pyrophosphatase, driving the reaction forward.
Role of Carnitine in Transport
Acyl-CoA cannot cross the inner mitochondrial membrane; converted to acylcarnitine.
Carnitine palmitoyltransferase-I transfers acyl groups to carnitine.
Acylcarnitine is transported into the matrix and converted back into acyl-CoA by carnitine palmitoyltransferase-II.
β-Oxidation of Fatty Acids
Mechanics of β-Oxidation
Two-carbon units are cleaved from acyl-CoA sequentially, forming acetyl-CoA.
Each cycle produces FADH2 and NADH, which generate ATP through oxidative phosphorylation.
The cycle requires oxygen and is catalyzed by specific enzymes at each step.
ATP Yield from Fatty Acid Oxidation
Complete oxidation of palmitate (C16) generates significant ATP (106 mol net).
Breakdown involves seven cycles producing 8 mol of acetyl-CoA.
FADH2 and NADH contribute to ATP synthesis.
Modified β-Oxidation in Peroxisomes
Shortening Very-Long-Chain Fatty Acids
Modified β-oxidation exists in peroxisomes for very long-chain fatty acids.
Does not generate ATP directly but forms acetyl-CoA and H2O2.
Ketonogenesis Under High Fatty Acid Oxidation Rates
Ketone Bodies Formation
Under high fatty acid oxidation, acetoacetate and D-3-hydroxybutyrate are formed in the liver.
Extrahepatic tissues utilize these as energy substrates.
Elevated levels can lead to ketosis, especially under fasting conditions.
Regulation of Ketogenesis
FFA Mobilization from Adipose Tissue
Involves lipolysis in response to energy needs.
Transport into Mitochondria
Carnitine palmitoyltransferase-I mediates the entry of fatty acids.
Partition of Acetyl-CoA
Determines flow between ketogenesis and the citric acid cycle.
Regulation impacts energy yield per oxidation.
Clinical Aspects
Diseases Related to Fatty Acid Oxidation
Carnitine deficiencies lead to hypoglycemia.
Inherited deficiencies such as CPT-I or CPT-II affect energy metabolism.
Jamaican vomiting sickness and dicarboxylic aciduria highlight pathological cases.
Ketoacidosis
Prolonged elevation of ketone bodies leads to acidosis, especially in diabetes.
Summary
Fatty acid oxidation yields ATP through the β-oxidation and citric acid cycle processes.
Ketogenesis serves a critical role in energy metabolism, particularly when glucose is low.
Diseases associated with disturbed fatty acid oxidation demonstrate the pathway's clinical significance.